Effects of SuperUlam on Supporting Concentration and Mood: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Table 5

Effect of treatment on CNS vital signs testing.

Units (ms)

Baseline (mean ± SE)

Hour 1 (mean ± SE)

Hour 2 (mean ± SE)

Hour 3 (mean ± SE)

Hour 4 (mean ± SE)

Hour 5 (mean ± SE)

SuperUlam

Placebo

SuperUlam

Placebo

SuperUlam

Placebo

SuperUlam

Placebo

SuperUlam

Placebo

SuperUlam

Placebo

Cognitive flexibility

115.25±2.07

111.60±3.37

116.45±1.63

115.70±3.75

112.35±5.11

112.60±3.60

118.90±1.75

113.45±3.42

119.75±1.60

117.55±2.26

117.25±2.27

116.85±2.37

Reaction time

104.25±2.66

100.65±3.24

101.95±2.97

99.25±3.24

100.45±3.19

106.60±3.76

103.25±3.14

100.90±2.98

100.90±3.56

101.15±3.65

101.60±3.51

102.55±2.90

Complex attention

106.65±2.36

101.40±3.94

108.75±1.56

106.80±3.22

101.50±5.93

98.50±5.39

106.70±2.58

96.60±5.68

110.15±7.55

104.65±3.15

106.20±2.29

105.10±3.50

Working memory

97.05±2.79

97.95±4.02

97.20±2.58

97.50±3.49

98.25±3.11

95.75±3.67

99.35±2.99

96.70±3.44

98.40±3.80

96.55±3.25

102.15±3.06

95.35±4.28

Sustained attention

97.25±3.45

97.30±4.08

97.75±3.30

99.05±3.27

97.65±2.44

94.60±4.16

96.15±4.30

97.20±3.35

99.90±3.79

96.70±3.72

97.25±4.47

95.30±3.98

Executive functioning

115.95±2.03

112.45±3.46

116.60±1.60^a

116.05±3.80

112.85±5.10

114.40±3.42

118.95±1.68

114.45±3.43

120.15±1.57

118.20±2.19

117.90±2.08

117.05±2.26

Processing speed

108.70±3.02

103.85±2.98

108.35±3.52

109.75±3.81

115.75±3.34

114.40±3.08

113.60±2.85

112.45±3.72

117.25±3.57

115.40±2.96

117.90±2.67

115.40±3.62

Average standard score

106.46±1.83

103.60±2.48

106.72±1.72

106.30±2.46

105.54±3.15

105.27±2.34

108.15±1.63

104.53±2.67

109.51±1.73

107.16±2.08

108.62±1.69

106.81±1.82

aP < 0.05 versus placebo at this time point.